Valuation: genOway

Market Cap 22.87M 26.03M 21.26M 19.51M 36.66M 2.51B 37.23M 253M 98.65M 1.23B 97.73M 95.63M 4.26B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.58M 33.68M 27.51M 25.25M 47.44M 3.24B 48.17M 327M 128M 1.59B 126M 124M 5.51B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
Current month+4.64%
1 month+5.08%
3 months-0.80%
6 months-3.12%
Current year-8.49%
1 week 2.47
Extreme 2.47
2.51
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 A Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 A Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 A Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-17.61%-34.04% 26.03M
+1.86%-1.24%-1.27%+11.29% 46.86B
+0.25%+1.65%+399.22%+647.65% 40.23B
-0.27%+4.45%+11.81%+60.81% 36.23B
+0.35%+0.87%+4.46%-10.31% 34.72B
+3.14%+1.02%+4.76%+43.00% 27.89B
-0.73%+11.84%+34.39%+134.44% 16.79B
+0.47%-2.74% - - 16.74B
+0.90%-5.77%+2.42%+7.89% 13.12B
-2.68%-2.49%-11.36%-34.51% 12.7B
Average +0.33%+0.40%+47.42%+91.80% 24.53B
Weighted average by Cap. +0.65%+0.91%+75.17%+138.03%

Financials

2024 2025
Net sales 27.53M 31.35M 25.6M 23.49M 44.14M 3.02B 44.83M 304M 119M 1.48B 118M 115M 5.13B 28.6M 32.56M 26.6M 24.41M 45.86M 3.14B 46.57M 316M 123M 1.54B 122M 120M 5.33B
Net income 1.83M 2.08M 1.7M 1.56M 2.94M 201M 2.98M 20.22M 7.9M 98.69M 7.82M 7.66M 341M 928K 1.06M 863K 792K 1.49M 102M 1.51M 10.25M 4M 50.01M 3.97M 3.88M 173M
Net Debt 623K 709K 579K 532K 999K 68.31M 1.01M 6.88M 2.69M 33.58M 2.66M 2.61M 116M 6.72M 7.65M 6.25M 5.73M 10.77M 737M 10.94M 74.19M 28.99M 362M 28.71M 28.1M 1.25B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
27/07/26 2.480 0.00% 399
24/07/26 €2.480 +0.40% 13,571
23/07/26 €2.470 -1.20% 17,468
22/07/26 €2.500 0.00% 1,510
21/07/26 €2.500 +0.81% 3,356
  1. Stock Market
  2. Stocks
  3. ALGEN Stock